Navigation Links
Helix BioPharma Corp. Announces Fiscal 2008 Results

nt's Discussion and Analysis and Annual Information Form are being filed today with Canadian securities regulatory authorities and will be available at SEDAR at

About Helix BioPharma Corp.

Helix BioPharma Corp. is a biopharmaceutical company specializing in the field of cancer therapy. The Company is actively developing innovative products for the prevention and treatment of cancer based on its proprietary technologies. Helix's product development initiatives include its Topical Interferon Alpha-2b and its novel L-DOS47 new drug candidate. Helix is listed on the TSX under the symbol "HBP".

For further information contact:

Investor & Media Relations

Ian Stone

Russo Partners LLC

Tel: (619) 814-3510

Fax: (619) 955-5318


David Schull

Russo Partners LLC

Tel: (212) 845-4271


The Toronto and Frankfurt Stock Exchanges have not reviewed and do not accept responsibility for the adequacy or accuracy of the content of this News Release. Reported financial information may not necessarily be indicative of future operating results or of future financial position, due to a number of risks and uncertainties, including those set forth below. This News Release contains certain forward-looking statements and information regarding anticipated developments in the Company's business and the sufficiency of the Company's cash reserves and expected cash flow from operations, which statements and information can be identified by the use of forward-looking terminology such as "to perform", "to develop", "in preparation for", "in anticipation of", "to

SOURCE Helix BioPharma Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Helix Biopharma Closes $11.4 Million Private Placement
2. Helix BioPharma Announces $11.4 Million Private Placement
3. Helix BioPharma to Present L-DOS47 Research Findings at the National Research Council of Canadas Eighth Annual General Meeting of the Genomics and Health Initiative in Saskatoon, Canada
4. Sigma-Aldrich Announces Collaboration With Metahelix Life Sciences
5. Helix BioPharma product development update, quarterly highlights and financial results for fiscal Q3 2008
6. W. Thomas Hodgson appointed to board of Helix BioPharma Corp.
7. Helix BioPharma reports Q2 2008 highlights, financial results
8. Helix BioPharma shareholders vote in favour of management
9. Helix BioPharma Corp. contracts KBI Biopharma to develop an L-DOS47 clinical packaging format
10. Helix BioPharma closes $16.9 million private placement of common shares
11. Helix BioPharma announces Q1 2008 financial results
Post Your Comments:
(Date:10/30/2014)... -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ), the ... a company overview at the Nomura Biotechnology Conference on Thursday, ... Boston, MA. A live webcast of ... section of the Company,s website, .  A replay ... and will be archived for a limited time. ...
(Date:10/30/2014)... challenges in the development of quantum technologies has been ... paper published today (28 October) in Nature Communications ... make a new type of flexibly designed microscopic trap ... sensors and specialised superfast computers, often depend on harnessing ... trapping these tiny particles are hugely problematic because of ...
(Date:10/27/2014)... October 27, 2014 The new ... Type (High & Medium), Sub-type (Primary & Secondary), ... Infrastructure & Transportation & Power Generation) - Trends ... GIS market with analysis and forecasting of the ... Data Tables with 52 Figures spread through 146 ...
(Date:10/27/2014)... NEW YORK , Oct. 27, 2014 ... in the recent Ebola concern in the ... for the virus.  The healthcare market researcher said the ... of in vitro diagnostic tests for the detection of ... sensitivity has proved useful.  Kalorama routinely assess the IVD ...
Breaking Biology Technology:Isis Pharmaceuticals to Present at the Nomura Biotechnology Conference 2Gas Insulated Switchgear Market worth $21,951.9 Million by 2019 - New Report by MarketsandMarkets 2Gas Insulated Switchgear Market worth $21,951.9 Million by 2019 - New Report by MarketsandMarkets 3Gas Insulated Switchgear Market worth $21,951.9 Million by 2019 - New Report by MarketsandMarkets 4Kalorama: PCR The Go-to Test in Ebola Fight 2Kalorama: PCR The Go-to Test in Ebola Fight 3
... 2011 SeraCare Life Sciences, Inc. (NASDAQ: ... products and services to facilitate the discovery, development and ... election of Joseph Nemmers and Kevin Hrusovsky to its ... has been appointed to the position of Chairman of ...
... 2011 OncoSec Medical Inc. (OTCBB: ONCS), a ... treat solid tumor cancers that have unmet medical ... to its leadership team. Formed earlier this year, ... for its tumor-destroying, tissue-sparing ElectroOncology therapies before the ...
... a one-atom thick sheet of carbon atoms arranged ... that has taken scientific communities and industrial sectors ... such as high current-carrying capacity and thermal conductivity, ... semiconductor circuits and computers. Moreover, it enables table-top ...
Cached Biology Technology:SeraCare Announces the Election of Joseph Nemmers and Kevin Hrusovsky to the Board of Directors 2SeraCare Announces the Election of Joseph Nemmers and Kevin Hrusovsky to the Board of Directors 3SeraCare Announces the Election of Joseph Nemmers and Kevin Hrusovsky to the Board of Directors 4OncoSec Announces Leadership Team Appointments 2OncoSec Announces Leadership Team Appointments 3OncoSec Announces Leadership Team Appointments 4Why graphene holds the key to the future 2
(Date:10/27/2014)... Ga. – Multiple times each day, about a third ... pressure – for at least an hour after the ... , Now they want to know how chronic mental ... response so they can determine the best ways to ... sodium is bad for you – these patients have ...
(Date:10/27/2014)... — Recent breakthroughs may pave the way for ... parasitic helminths. These flatworms, including tapeworms that cause ... flukes (schistosomes), infect more than 300 million people ... lost due to chronic illness and death each ... of microbiology, immunology, and tropical medicine, and scientific ...
(Date:10/27/2014)... /CNW/ - A robust contingent of Canadian researchers will present ... (HIV R4P) Conference in Cape Town, South Africa ... Oct. 28 to 31 is expected to attract up to ... HIV R4P is the world,s first and only scientific meeting ... Twenty nine oral and poster presentations will be made by ...
Breaking Biology News(10 mins):Researchers look for the best way to help shake too much sodium 2Researchers look for the best way to help shake too much sodium 3Researchers look for the best way to help shake too much sodium 4GW researcher adapting breakthrough technologies to combat parasitic worm infections 2Canadian Research Well Represented at HIV Prevention Conference 2
... their offspring so they inherit either their mother,s or ... offspring are more likely to have daughters. Weaker ... produce more sons. The study, by scientists at ... University (Japan), is published today (9 January) in the ...
... effect on alpine vegetation than at first anticipated, according to ... and published in Nature Climate Change . The first ... some alpine meadows could disappear within the next few decades. ... Sciences and the University of Vienna, biologists from 13 different ...
... warmest since global climate has been measured, and while ... plant communities that reflect this warming trend, no study ... until now. With the publication of "Continent-wide ... Advance Online Publication (AOP) in Nature Climate Change ...
Cached Biology News:Fit females make more daughters, mighty males get grandsons 2Climate change is altering mountain vegetation at large scale 2European mountain vegetation shows effects of warmer climate 2
The pCDF Expression System 1 plus Competent Cells contains 10 µg of pET-45b(+) DNA. pET-45b carries an N-terminal His•Tag ® coding sequence that is cleavable with enterokinase as well...
Nucleobindin 1 [NUCB1]...
Request Info...
... cells (HSC) are well-characterized tissue-specific stem cells ... responsible for the life-long maintenance of the ... reside in adult bone marrow where hematopoiesis ... be found in cord blood, fetal liver, ...
Biology Products: